Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.

about

A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.Emerging drugs for graft-versus-host disease.

P2860

Q33435568-C13D11EE-762A-4773-9B5F-73520E32251D Q38786084-9DD3D7B6-5D9E-4C7D-9705-3F38B22FCDA2

P2860

Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.

Item

http://www.wikidata.org/entity/Q36813127

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Phase I study of alemtuzumab f ...... nic graft-versus-host disease.

@ast

Phase I study of alemtuzumab f ...... nic graft-versus-host disease.

@en

type

Item

label

Phase I study of alemtuzumab f ...... nic graft-versus-host disease.

@ast

Phase I study of alemtuzumab f ...... nic graft-versus-host disease.

@en

prefLabel

Phase I study of alemtuzumab f ...... nic graft-versus-host disease.

@ast

Phase I study of alemtuzumab f ...... nic graft-versus-host disease.

@en

P1476

Phase I study of alemtuzumab f ...... nic graft-versus-host disease.

@en

P2093

Bhavjot Bindra

http://www.w3.org/2001/XMLSchema#string

Brett Glotzbecker

http://www.w3.org/2001/XMLSchema#string

Corey S Cutler

http://www.w3.org/2001/XMLSchema#string

Edwin P Alyea

http://www.w3.org/2001/XMLSchema#string

Haesook T Kim

http://www.w3.org/2001/XMLSchema#string

Jerome Ritz

http://www.w3.org/2001/XMLSchema#string

John Koreth

http://www.w3.org/2001/XMLSchema#string

Joseph H Antin

http://www.w3.org/2001/XMLSchema#string

Philippe Armand

http://www.w3.org/2001/XMLSchema#string

Robert J Soiffer

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of chronic graft-versus-host disease in 2011

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.

Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.

Advances in graft-versus-host disease biology and therapy.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis.

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

P304

804-811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2013.02.009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Bruce R Blazar

P577

2013-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235649048

http://www.w3.org/2001/XMLSchema#string

P698

23416855

http://www.w3.org/2001/XMLSchema#string

P932

3642980

http://www.w3.org/2001/XMLSchema#string

Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.

about

P2860

P2860

Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932